Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung CancerHiroyuki Yasuda, Daniel B. Costa, Eunyoung Park et al.|Science Translational Medicine|2013Cited by 565
BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR MutationsDaniel B. Costa, Susumu Kobayashi|PLoS Medicine|2007Cited by 490
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Kwok‐Kin Wong, Danan Li et al.|Cancer Cell|2006Cited by 451
Novel <i>PINK1</i> mutations in early‐onset parkinsonismNobutaka Hattori, Shuichi Asakawa, Yasuhisa Yamamura et al.|Annals of Neurology|2004Cited by 244
<i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancerToshiyuki Hirano, Kenzo Soejima, Hiroyuki Yasuda et al.|Oncotarget|2015Cited by 159